DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2271777/equillium-inc-eq-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271777 May 09, 2024 - Equillium (EQ) delivered earnings and revenue surprises of 52.94% and 16.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271763/arcellx-inc-aclx-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271763 May 09, 2024 - Arcellx (ACLX) delivered earnings and revenue surprises of 72.55% and 32.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271793/kronos-bio-inc-kron-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271793 May 09, 2024 - Kronos Bio (KRON) delivered earnings and revenue surprises of -16.28% and 68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271811/inseego-insg-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271811 May 09, 2024 - Inseego (INSG) delivered earnings and revenue surprises of 26.53% and 8.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271833/arcadia-biosciences-rkda-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271833 May 09, 2024 - Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271798/integral-ad-science-ias-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271798 May 09, 2024 - Integral Ad Science (IAS) delivered earnings and revenue surprises of 50% and 2.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271790/anaptysbio-inc-anab-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271790 May 09, 2024 - AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2271820/silver-spike-investment-corp-ssic-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2271820 May 09, 2024 - Silver Spike Investment (SSIC) delivered earnings and revenue surprises of -112.50% and 15.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2272398/are-you-looking-for-a-top-momentum-pick-why-itron-itri-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2272398 May 10, 2024 - Does Itron (ITRI) have what it takes to be a top stock pick for momentum investors? Let's find out. 0

https://www.zacks.com/commentary/2272277/top-stock-reports-for-amazon-com-visa-pfizer?cid=CS-ZC-FT-research_daily-2272277 May 10, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE). 0